menu
    • menu

    Company profile for IntoCell

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    IntoCell was established with a bold vision of commercializing innovative ADC platform technologies based on creative ideas and technical excellence, breaking away from traditional small molecule-based drug discovery and development. IntoCell’s leadership team has already had management experience of co-founding a venture company that subsequently listed on the KOSDAQ stock exchange. By combining extensive experience of succ...
    IntoCell was established with a bold vision of commercializing innovative ADC platform technologies based on creative ideas and technical excellence, breaking away from traditional small molecule-based drug discovery and development. IntoCell’s leadership team has already had management experience of co-founding a venture company that subsequently listed on the KOSDAQ stock exchange. By combining extensive experience of successfully developing ADC technologies with a broad industry network, we are confident that our vision will come to be realized.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    IntoCellkorearepublicofnew Flag
    Country
    Country
    South Korea
    Address
    Address
    101, Sinildong-ro, Daedeok-gu, Daejeon
    Telephone
    Telephone
    +82 - 042 - 716 - 0083
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.intocell.co.kr/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Intocell, Xcellon Biologics Ink MOU To Boost Next-Gen ADC Tech
    Intocell, Xcellon Biologics Ink MOU To Boost Next-Gen ADC Tech

    31 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/31/3178341/0/en/IntoCell-and-Xcellon-Biologics-Announce-MOU-to-Expand-Access-to-Next-Generation-ADC-Technologies.html

    GLOBENEWSWIRE
    31 Oct 2025
    Share Share
    Piramal Teams Up With Intocell For ADC Development Opportunities
    Piramal Teams Up With Intocell For ADC Development Opportunities

    30 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/piramal-pharma-solutions-formalizes-partnership-with-intocell-expanding-its-payload-linker-platform-and-bioconjugate-capabilities-302599334.html

    PR NEWSWIRE
    30 Oct 2025
    Share Share
    IntoCell Enters into Development and License Agreement with ADC Therapeutics
    IntoCell Enters into Development and License Agreement with ADC Therapeutics

    04 Jan 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/intocell-enters-into-development-and-license-option-agreement-with-adc-therapeutics-301713606.html

    PR NEWSWIRE
    04 Jan 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search